Author ORCID Identifier
https://orcid.org/0000-0002-5809-8309
Date of Award
5-31-2026
Document Type
Open Access Dissertation
Degree Name
Doctor of Philosophy (PhD)
Department
Counseling
First Advisor
Lisa Cosgrove
Second Advisor
Boaz Levy
Abstract
Youth in the U.S. and internationally are increasingly being diagnosed with depression and related psychiatric conditions (Murthy, 2021) many of whom are being subjected to non-evidence-based, or what has been termed irrational, psychotropic polypharmacy (Barnett & Concepcion Zayas, 2019). Psychotropic polypharmacy can be defined as “the use of 2 or more psychiatric medications in the same patient,” (Zito et al., 2021) though definitions can vary. Using data from the Center for Health Information Analysis’ Massachusetts All-Payer Claims Database, this study examined the sociodemographic factors associated with high rates of polypharmacy, a hypothesized increase in pediatric psychotropic polypharmacy rates in Massachusetts during the COVID-19 pandemic compared to the rates before the pandemic, and the classes of psychotropic medications being prescribed concurrently at the highest rates from 2018-2022. The findings revealed the main sociodemographic factors that were associated with higher rates of polypharmacy were being a male and having an older age, an increase of pediatric psychotropic polypharmacy rates in Massachusetts from 2018-2022, and the classes of psychotropic medications being prescribed concurrently at the highest rates from 2018-2022 as stimulants, “other” psychotropic medications (which included Clonidine Hydrochloride, Guanfacine, Propranolol Hydrochloride, Prazosin Hydrochloride), anti-anxiety medications, antidepressants, mood stabilizers, antipsychotics, and hypnotics. The contributions from this study underscore the need for state-level monitoring systems, deprescribing initiatives, and trauma-informed, non-pharmacologic interventions to ensure more equitable care for children and adolescents.
Recommended Citation
D'Ambrozio, Gianna, "Trends of Pediatric Psychotropic Polypharmacy in Massachusetts Before and During the COVID-19 Pandemic" (2026). Graduate Doctoral Dissertations. 1137.
https://scholarworks.umb.edu/doctoral_dissertations/1137
Included in
Child Psychology Commons, Clinical Psychology Commons, COVID-19 Commons, Health Psychology Commons, Other Psychiatry and Psychology Commons, Psychiatric and Mental Health Commons
Comments
Free and open access to this Campus Access Thesis is made available to the UMass Boston community by ScholarWorks at UMass Boston. Those not on campus and those without a UMass Boston campus username and password may gain access to this thesis through Interlibrary Loan. If you have a UMass Boston campus username and password and would like to download this work from off-campus, click on the “Off-Campus Users” button.